{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:52:26Z","timestamp":1756385546887},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaad.2017.07.054","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:01:41Z","timestamp":1510682501000},"page":"223-230.e3","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Herpes zoster in hospitalized adults: Practice gaps, new evidence, and remaining questions"],"prefix":"10.1016","volume":"78","author":[{"given":"Iris","family":"Ahronowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.07.054_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","article-title":"Incidence of herpes zoster and its complications in Germany, 2005-2009","volume":"70","author":"Hillebrand","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jaad.2017.07.054_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/ijerph6092344","article-title":"Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms","volume":"6","author":"Gabutti","year":"2009","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jaad.2017.07.054_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.20344\/amp.312","article-title":"Hospital admissions for herpes zoster in Portugal between 2000 and 2010","volume":"26","author":"Mesquita","year":"2013","journal-title":"Acta Med Port"},{"key":"10.1016\/j.jaad.2017.07.054_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-015-1059-9","article-title":"Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France","volume":"15","author":"Blein","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib6","unstructured":"Centers for Disease Control and Prevention website. Shingles (herpes zoster). Preventing varicella-zoster virus (VZV) transmission from zoster in healthcare settings. Available at: http:\/\/www.cdc.gov\/shingles\/hcp\/hc-settings.html. Accessed September 17, 2016."},{"key":"10.1016\/j.jaad.2017.07.054_bib7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/infdis\/jis207","article-title":"Transmission of varicella zoster virus from individuals with herpes zoster or varicella in\u00a0school and day care settings","volume":"205","author":"Viner","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/infdis\/158.1.238","article-title":"Airborne transmission of nosocomial varicella from localized zoster","volume":"158","author":"Josephson","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/527419","article-title":"Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004","volume":"197","author":"Lopez","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/cid\/cir033","article-title":"Varicella reinfection in a seropositive physician following occupational exposure to localized zoster","volume":"52","author":"Johnson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/00365541003754436","article-title":"An outbreak of varicella in staff nurses exposed to a patient with localized herpes zoster","volume":"42","author":"Saidel-Odes","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/527420","article-title":"Varicella-zoster virus in the saliva of patients with herpes zoster","volume":"197","author":"Mehta","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/599381","article-title":"Viremia in acute herpes zoster","volume":"200","author":"Satyaprakash","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1086\/382029","article-title":"Detection of aerosolized varicella-zoster virus DNA in patients\u00a0with localized herpes zoster","volume":"189","author":"Suzuki","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/527421","article-title":"Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission","volume":"197","author":"Breuer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2017.07.054_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2017.07.054_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CNV-100000070","article-title":"A randomized, double-blind trial of famciclovir versus acyclovir for the\u00a0treatment of localized dermatomal herpes zoster in\u00a0immunocompromised patients","volume":"19","author":"Tyring","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jaad.2017.07.054_bib19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2017.07.054_bib20","first-page":"CD006866","article-title":"Antiviral treatment for preventing postherpetic neuralgia","volume":"6","author":"Chen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.07.054_bib21","first-page":"613","article-title":"A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group","volume":"4","author":"Ljungman","year":"1989","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jaad.2017.07.054_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5214\/ans.0972.7531.1118405","article-title":"A study on efficacy of pregabalin in acute herpetic neuralgia","volume":"18","author":"Kanodia","year":"2011","journal-title":"Ann Neurosci"},{"key":"10.1016\/j.jaad.2017.07.054_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/0019-5154.100476","article-title":"Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients","volume":"57","author":"Kanodia","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2017.07.054_bib24","first-page":"320","article-title":"Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study","volume":"33","author":"Lin","year":"2008","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.jaad.2017.07.054_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jcpt.12167","article-title":"Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials","volume":"39","author":"Fan","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaad.2017.07.054_bib26","first-page":"CD005582","article-title":"Corticosteroids for preventing postherpetic neuralgia","volume":"3","author":"Han","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.07.054_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/dth.12331","article-title":"Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study","volume":"93","author":"Lee","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.07.054_bib28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaad.2016.05.037","article-title":"Clinical and immunologic features of recurrent herpes zoster (HZ)","volume":"75","author":"Nakamura","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.07.054_bib29","first-page":"729","article-title":"Centers for Disease Control and Prevention (CDC). Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2017.07.054_bib30","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.07.054_bib31","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2017.07.054_bib32","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.07.054_bib33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaad.2017.07.054_bib34","unstructured":"Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Available at: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed September 17, 2016."},{"key":"10.1016\/j.jaad.2017.07.054_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/infdis\/jiv318","article-title":"Acyclovir prophylaxis reduces the incidence of herpes zoster among HIV-infected individuals: results of a randomized clinical trial","volume":"213","author":"Barnabas","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2017.07.054_bib36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2017.07.054_bib37","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jaad.2017.07.054_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.antiviral.2017.01.011","article-title":"Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"140","author":"Seo","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.jaad.2017.07.054_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bjhh.2016.05.015","article-title":"Herpes zoster after autologous hematopoietic stem cell transplantation","volume":"38","author":"Santos","year":"2016","journal-title":"Rev Bras Hematol E Hemoter"},{"key":"10.1016\/j.jaad.2017.07.054_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbmt.2016.12.620","article-title":"Herpes zoster in autologous hematopoietic cell transplant recipients in the era of acyclovir\u00a0or valacyclovir prophylaxis and novel treatment and maintenance therapies","volume":"23","author":"Sahoo","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jaad.2017.07.054_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2017.07.054_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12185-015-1810-4","article-title":"Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation","volume":"102","author":"Kawamura","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaad.2017.07.054_bib43","first-page":"701","article-title":"Prophylactic efficacy against herpes zoster and costs difference between acyclovir and valaciclovir in hematological patients","volume":"30","author":"Usami","year":"2016","journal-title":"Vivo Athens Greece"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217322004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217322004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:57:42Z","timestamp":1723665462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217322004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0190962217322004"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.07.054","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster in hospitalized adults: Practice gaps, new evidence, and remaining questions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}